Clinical trial
Clinical Efficacy of Tiotripium in Patients With Airflow Obstruction Due to TB Destroyed Lung
NCT01365702 is registered in ClinicalTrials.gov with Seoul National University Bundang Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Efficacy of Tiotripium in Patients With Airflow Obstruction Due to TB Destroyed Lung
- Lead sponsor
- Seoul National University Bundang Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 30, 2011
- Completion date
- December 31, 2012
- Enrollment
- 70 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lung disease, obstructive, tuberculosis